Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Trial of GC4419 in Patients With Critical Illness Due to COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04555096
Recruitment Status : Terminated (Participants are no longer receiving intervention)
First Posted : September 18, 2020
Last Update Posted : July 14, 2021
Information provided by (Responsible Party):
Galera Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 28, 2021
Actual Study Completion Date : May 28, 2021